Valeant shares down again: 5 key notes on the stock

Laval, Canada-based Valeant Pharmaceuticals stocks were down 4 percent from Dec. 22, 2016 to Dec. 29, 2016.

Advertisement

Here’s what you should know.

1. The stock’s five day high was $14.71 on Dec. 22, 2016.

2. Valeant’s stock hit a five day low of $13.82 on Dec. 28, 2016.

3. Its 52-week range was $13 to $105.93 per share.

4. The company has a market cap of $4.87 billion and a negative earnings per share of $6.48.

5. As of 11:30 a.m. Dec. 30, 2016, Valeant was trading at $14.58.

More articles on GI/endoscopy:
GI leader to know: Dr. Glenn Littenberg of Gastroenterology Associates
Future of esophageal screening may rest in patient’s nose: 5 key notes
GI leader to know: Dr. Nicholas Weber of CHI Franciscan Health

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.